Lynn Giam

 

 

 

 

 

 

 

 

 

 

 

 

 

Ms. Giam is a fundamental research analyst at Causeway. She joined the firm in July 2024. Her current responsibilities include coverage of companies in the industrials and energy sectors.
 
Prior to joining Causeway, Ms. Giam was an industrials research analyst at Point72 Asset Management. Before that, she was a research associate at Wellington Management.

Allison Liegner, CFA

 

 

 

 

 

 

 

 

 

 

 

 

 

Ms. Liegner is a fundamental research analyst at Causeway. She joined the firm in July 2024. Her current responsibilities include coverage of companies in the materials sector.
 
She interned at Causeway in the summer of 2023 on the materials and health care groups. She had a pre-MBA internship in equity research at T Rowe Price in 2022. Prior to joining Causeway, Ms. Liegner was a research associate at Wellington Management. From 2018-2019, she was a private equity analyst at Search Fund Accelerator.

Blake Mielke

 

 

 

 

 

 

 

 

 

 

 

 

 

Mr. Mielke is a fundamental research analyst at Causeway. He joined the firm in September 2023. His current responsibilities include coverage of companies in the technology and communication services sectors.

Prior to joining Causeway, Mr. Mielke was a senior equity research associate at Jefferies, covering communications infrastructure. From 2020 to 2021, he was an equity research associate at Stifel, covering application and security software.

Nicholas Wells, CFA

 

 

 

 

 

 

 

 

 

 

 

 

 

Mr. Wells is a fundamental senior research analyst at Causeway. He joined the firm in May 2023. His current responsibilities include coverage of companies in the consumer discretionary and consumer staples sectors.

Prior to joining Causeway, Mr. Wells was a partner at Poplar Forest Capital, covering the consumer discretionary, consumer staples, and materials sectors. From 2013 to 2017, he was a research associate at Capital Group Companies. Prior to that, Mr. Wells was a research associate at UBS Investment Bank.

Marshall Dong

 

 

 

 

 

 

 

 

 

 

 

 

 

Mr. Dong is a quantitative research analyst at Causeway. He joined the firm in March 2023. His current responsibilities include alpha research and alternative data analysis.

From 2020 to 2023, Mr. Dong was at data scientist at Point72 Asset Management, covering US industrials sector. Prior to that, he was a senior strategy/analytics consultant at Deloitte LLP.

Kathryn Hall

Kathryn Hall is a business development associate. She joined the firm in April 2022.

From 2021 to 2022, Ms. Hall worked in sales and marketing at Wisetail, an Intertek Company.

Danielle Durkovic

Danielle Durkovic is a reporting analyst. She joined the firm in November 2022.

Ryan Greenwald, CPA

Mr. Greenwald is a fundamental research analyst at Causeway. He joined the firm in November 2022 with current coverage responsibilities including global utilities & clean energy.

Prior to joining Causeway, Mr. Greenwald spent over five years as a sell side equity analyst supporting #1 Institutional Investor ranked teams at Bank of America and Wolfe Research, covering US utilities & clean energy along with airfreight & surface transportation.

Kate Byrne-Slepicka

Ms. Byrne-Slepicka is a fundamental research analyst at Causeway. She joined the firm in November 2022. Her current responsibilities include coverage of companies in the financials and materials sectors.

Prior to joining Causeway, Ms. Byrne-Slepicka was a senior investment risk analyst at Global Atlantic Financial Group. Prior to 2021, Ms. Byrne-Slepicka was an investment portfolio analyst at Global Atlantic.

Gavin Scott

Mr. Scott is a fundamental senior research analyst at Causeway. He joined the firm in August 2022. His current responsibilities include coverage of companies in the pharmaceuticals and biotechnology sectors.

Prior to joining Causeway, Mr. Scott was vice president of Equity Research Large Cap Biotech at J.P. Morgan. From 2017 to 2019, he was an associate at Goldman Sachs covering large cap biopharma. Prior to that, Mr. Scott was an associate at Jefferies LLC, covering Global Large Cap Pharma.